2.95
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Income/Loss |
11.69%
-3.4888
|
-3.9508 | -2.847 | -2.7347 | -3.4249 |
| Income/Loss From Continuing Operations Before Tax |
12.64%
-3.4366
|
-3.9339 | -2.8344 | -2.7287 | -3.3847 |
| Income/Loss From Continuing Operations After Tax |
12.64%
-3.4366
|
-3.9339 | -2.8344 | -2.7287 | -3.3847 |
|
|
12.64%
-3.4366
|
-3.9339 | -2.8344 | -2.7287 | -3.3847 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
205.25%
47.53
|
15.57 | 9.5268 | 0.15 | 3.276 |
| Diluted Average Shares |
205.25%
47.53
|
15.57 | 9.5268 | 0.15 | 3.276 |
| Basic Earnings Per Share |
72.00%
-0.07
|
-0.25 | -0.30 | -0.74 | -1.03 |
| Diluted Earnings Per Share |
72.00%
-0.07
|
-0.25 | -0.30 | -0.74 | -1.03 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):